Paraadrenal Castleman disease presenting with adrenal hyperandrogenism

Journal of Endocrinological Investigation

Volumn 29, Issue 2, 2006, Pages 172-176

  Müssig, Karsten ^a   Gallwitz, B ^a   Machicao, F ^a   Horger, M ^a   Haring H U ^a   Kaiserling, E ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Adrenal hyperandgrogenism; Angiofollicular lymph node hyperplasia; Castleman disease; Hyaline vascular type; Interleukin 6

Indexed keywords

ANDROSTENEDIONE; COMPLEMENTARY DNA; DEXAMETHASONE; INTERLEUKIN 6; NITRENDIPINE; PRASTERONE SULFATE; TESTOSTERONE;

ABDOMINAL RADIOGRAPHY; ADRENALECTOMY; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EMBEDDING; ENDOCRINE FUNCTION TEST; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERANDROGENISM; HYPERTENSION; IMAGE DISPLAY; LAPAROSCOPIC SURGERY; PATHOPHYSIOLOGY; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE SECTION;

EID: 33645557256     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344093     Document Type: Article

References (24)

1. Irsutti M, Paul JL, Selves J, Railhac JJ. Castleman disease: CT and MR imaging features of a retroperitoneal location in association with paraneoplastic pemphigus. Eur Radiol 1999, 9: 1219-21.
2. Debatin JF, Spritzer CE, Dunnick NR. Castleman disease of the adrenal gland: MR imaging features. AJR Am J Roentgenol 1991, 157: 781-3.
3. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29: 577-80.
4. Azziz R, Bradley EL Jr, Potter HD, Boots LR. Adrenal androgen excess in women: lack of a role for 17-hydroxylase and 17,20-lyase dysregulation. J Clin Endocrinol Metab 1995, 80: 400-5.
5. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998, 128: 127-37.
6. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP. Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997, 66: 54-62.
7. Mastorakos G, Weber JS, Magiakou MA, Gunn H, Chrousos GP. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion. J Clin Endocrinol Metab 1994, 79: 934-9.
8. van Gool J, van Vugt H, Helle M, Aarden LA. The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990, 57: 200-10.
9. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP. Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J Clin Endocrinol Metab 1996, 81: 2303-6.
10. Lyson K, McCann SM. The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1991, 54: 262-6.
11. Mastorakos G, Chrousos GP, Weber JS. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77: 1690-4.
12. Naitoh Y, Fukata J, Tominaga T, et al. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem Biophys Res Commun 1988, 155: 1459-63.
13. Salas MA, Evans SW, Levell MJ, Whicher JT. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 1990, 79: 470-3.
14. Päth G, Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA. Interleukin-6 and the interleukin-6 receptor in the human adrenal gland: expression and effects on steroidogenesis. J Clin Endocrinol Metab 1997, 82: 2343-9.
15. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989, 74: 1360-7.
16. Kishimoto T, Akira S, Narazaki M, Taga T. Interleukin-6 family of cytokines and gp130. Blood 1995, 86: 1243-54.
17. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993, 20: 636-47.
18. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990, 86: 592-9.
19. Leger-Ravet MB, Peuchmaur M, Devergne O, et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991, 78: 2923-30.
20. Mandler RN, Kerrigan DP, Smart J, Kuis W, Villiger P, Lotz M. Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer 1992, 69: 2697-703.
21. Adelman HM, Cacciatore ML, Pascual JF, Mike JM, Alberts WM, Wallach PM. Case report: Castleman disease in association with POEMS. Am J Med Sci 1994, 307: 112-4.
22. Papanicolaou DA, Petrides JS, Tsigos C, et al. Exercise stimulates interleukin-6 secretion: inhibition by glucocorticoids and correlation with catecholamines. Am J Physiol 1996, 271: E601-5.
23. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev 2000, 21: 347-62.
24. Mowszowicz I, Melanitou E, Doukani A, Wright F, Kuttenn F, Mauvais-Jarvis P. Androgen binding capacity and 5 alpha-reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab 1983, 56: 1209-13.